Findings indicate that the test demonstrated 89.2% sensitivity and 87.8% specificity for detecting high-grade or invasive bladder cancer, surpassing the nuclear matrix protein 22 (NMP22 ...

Investigators compared a urinary DNA methylation test with the nuclear matrix protein 22 (NMP22) and urine cytology tests.

A urinary DNA methylation test displayed superior sensitivity for detecting high-grade or invasive bladder cancer, compared with the nuclear matrix protein 22 (NMP22) test or urine cytology test.